Dermatological complications of etanercept therapy for rheumatoid arthritis.
Misery
L
L
Perrot
J L
JL
Gentil-Perret
A
A
Pallot-Prades
B
B
Cambazard
F
F
Alexandre
C
C
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003449:Cryoglobulinemia / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D008179:Lupus Erythematosus, Discoid / Q000139:chemically induced*; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept